Bill
HR 5160
Stem Cell Therapeutic and Research Reauthorization Act of 2025
119th Congress
Introduced by Robert Aderholt and 20 co-sponsors
HR 5160 reauthorizes federal funding for stem cell research, enhancing treatment options for patients and supporting innovation in medical therapies and research collaborations.
Motion to reconsider laid on the table Agreed to without objection.